Alnylam Pharmaceuticals
ALNY
#706
Rank
NZ$61.23 B
Marketcap
NZ$458.61
Share price
-1.61%
Change (1 day)
-14.73%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company